COMPARATIVE EVALUATION OF INVASIVE AND NON-INVASIVE METHODS OF TREATMENT OF ISCHEMIC HEART DISEASE
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Main Article Content
Abstract:
The paper presents statistical data, including the situation in Uzbekistan, as well as the results of the analysis of retrospective data of 250 patients treated with various methods. The aim of the study is to compare the effectiveness of invasive and non-invasive methods of treatment of coronary heart disease (CHD) in terms of clinical results, safety and prognosis. The results show that invasive methods demonstrate better short-term outcomes, while non-invasive methods remain significant in patients with mild and moderate forms of the disease. The best results are achieved with a combined approach.
Article Details
How to Cite:
References:
World Health Organization. Cardiovascular diseases (CVDs) – Fact sheet, 2023.
Neumann FJ, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019.
Boden WE, et al. Optimal medical therapy with or without PCI. N Engl J Med. 2020.
Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier, 2021.
Stone GW, et al. Outcomes after PCI: real-world data. JACC. 2021.
Fox K, et al. Percutaneous coronary interventions in stable angina. BMJ. 2021.
Patel MR, et al. ACC/AHA guidelines for stable ischemic heart disease. Circulation. 2021.
Fihn SD, et al. Strategies for ischemic heart disease: invasive vs conservative. JAMA. 2019.
Bhatt DL, et al. Invasive vs conservative therapy in stable ischemic heart disease. NEJM. 2022.
Министерство здравоохранения Республики Узбекистан. Статистика по сердечно-сосудистым заболеваниям. 2023.
Махмудов Ш.К. и др. Эпидемиология ИБС в Узбекистане. Узмеджурнал, 2022.
Weintraub WS, et al. PCI and long-term survival. JACC. 2021.
Hachamovitch R, et al. Revascularization vs medical therapy. JACC. 2019.
Dagenais GR, et al. Long-term outcomes with medical therapy. Circulation. 2020.
Yusuf S, et al. Modifiable risk factors in MI: INTERHEART study. Lancet. 2020.
Windecker S, et al. Revascularization strategies. Eur Heart J. 2022.
Бобоев Х.Б. и др. Сравнение лечения ИБС в Узбекистане. Журн. кардиологии, 2023.
Nallamothu BK, et al. Risk-benefit in coronary interventions. Circulation. 2020.
Goyal A, et al. Clinical outcomes in ischemic heart disease. JAMA Intern Med. 2023.
Malkin CJ, et al. PCI in elderly patients. Heart. 2020.